TNBI · Tanke Biosciences Corp
Market Cap
$399,722
Shares
13.32M
Volume · Oct 29
400
Avg daily vol (10 sessions)
147.35K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.03
Open$0.01
Day$0.01–0.03
52W close$0.01–0.06
Avg vol 30d61K
Short int411 · 0.0% of shares · 1.0d
Short vol76%
DataFeb 2020–Oct 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$22.96M
Trailing 12 months
Net income (TTM)
−$1.64M
Trailing 12 months
Revenue growth YoY
-39.0%
Year over year
Operating margin
-0.2%
Trailing 12 months
P / E (TTM)
0.1
Trailing earnings · reciprocal yield 724.6%
FCF yield
-1,532.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$3.18M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
-44.8%
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.72
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+6%
above
Price vs 50-day avg
−28%
below
RSI (14)
49
neutral
MACD trend
Negative
52-week position
35%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−31%
trailing
6-month return
+176%
trailing
YTD return
−8%
this year
Relative strength
+172%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
+20%
Y/Y
Gross margin
35%
contracting
EPS growth
−171%
Y/Y
Balance sheet
$4.1M
net cash
Quant / Vol
risk profile
Volatility
640%
annualized · 1-yr
Max drawdown
−94%
past year
ATR
37.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+6%
Bullish
Price vs 50-day avg
−28%
Bearish
RSI (14)
49
Neutral
MACD trend
Negative
Bearish
52-week position
35%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 35%
Range high $0
vs 200-day avg +6%
vs 50-day avg -28%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TNBI
this stock
Tanke Biosciences Corp
|
$399,722 | -8.0% | +19.8% | — | 0.0% |
|
BLK
BlackRock, Inc.
|
$394.26B | +13.7% | +16.2% | 27.7 | 0.7% |
|
BN
BROOKFIELD Corp
|
$92.96B | -9.3% | — | — | 0.0% |
|
BX
Blackstone Inc.
|
$89.04B | -23.1% | +9.2% | 26.4 | 2.6% |
|
KKR
KKR & Co. Inc.
|
$86.72B | -23.8% | -11.0% | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TNBI | +3.0% | -31.0% | +176.0% | +176.0% | -8.0% |
| SPY | +0.7% | +0.7% | +4.3% | +0.9% | +12.8% |
| vs SPY | +2.3% | -31.7% | +171.7% | +175.1% | -20.8% |